PizzaDAO Celebrates Third Annual Global Pizza Party
PHILADELPHIA, PA, May 20, 2023 – (ACN Newswire) – PizzaDAO, a global pizza co-op and…
News
C3.AI INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of C3.ai, Inc. – AI
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at…
Personas Announces a $650,000 Non-Brokered Private Placement
Toronto, Ontario–(Newsfile Corp. – May 19, 2023) – Personas Social Incorporated (TSXV: PRSN) (the “Company“) is…
DISH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DISH Network Corporation and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds…
STEER Provides Update on Settlement Agreement with the Ontario Securities Commission
TORONTO–(BUSINESS WIRE)–$STEEF #Technology–STEER Technologies Inc. (“STEER” or the “Company”) (TSXV: STER) (OTCQX: STEEF), an integrated…
Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence
– Dyno bCap 1 exhibits 100x improvement versus AAV9 in delivery to the central nervous…
FVCbank Captures Coveted Bank Honor Roll Recognition for Strong Earnings Growth Over the Past Decade
FAIRFAX, Va.–(BUSINESS WIRE)–Fairfax-based FVCbank has been honored by Keefe, Bruyette & Woods, Inc. (KBW) by…
Edifecs to Present and Sponsor 2023 WEDI Spring Conference
Edifecs executives lead conversations on interoperability, health equity, and prior authorization BELLEVUE, Wash.–(BUSINESS WIRE)–Edifecs, Inc.,…
CyrusOne Announces CFO Transition
DALLAS–(BUSINESS WIRE)–Today CyrusOne announces that Chief Financial Officer Katherine Motlagh will step down from her…
Notice of Wrongdoing by Daihatsu in Collision Tests and Sales and Shipment Suspension of Toyota RAIZE
Toyota City, Japan, May 19, 2023 – (JCN Newswire) – It has been discovered that…
KKR Names Dan Pietrzak Global Head of Private Credit
NEW YORK–(BUSINESS WIRE)–KKR, a leading global investment firm, today announced it has named Dan Pietrzak…
Ipsen receives positive opinion in Europe for Dysport® in the management of urinary incontinence in adults with neurogenic detrusor overactivity due to multiple sclerosis or spinal cord injury
Submission based on data from the pivotal international Phase III CONTENT clinical program, also recently…
Ipsen receives positive opinion in Europe for Dysport® in the management of urinary incontinence in adults with neurogenic detrusor overactivity due to multiple sclerosis or spinal cord injury
Submission based on data from the pivotal international Phase III CONTENT clinical program, also recently…
Orchard Therapeutics Announces Positive Clinical and Preclinical Data in Programs Targeting Neurometabolic and CNS Disorders at ASGCT
New OTL-203 proof-of-concept data demonstrate extensive metabolic correction in the skeletal system of patients with…
Orchard Therapeutics Announces Positive Clinical and Preclinical Data in Programs Targeting Neurometabolic and CNS Disorders at ASGCT
New OTL-203 proof-of-concept data demonstrate extensive metabolic correction in the skeletal system of patients with…
Cytek Biosciences Announces $50 Million Stock Repurchase Program
FREMONT, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
Cytek Biosciences Announces $50 Million Stock Repurchase Program
FREMONT, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
Candel Therapeutics Announces New Data from Ongoing Phase 1 Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
Treatment with CAN-3110 in arm A showed encouraging median overall survival rate at 11.8 months…
Candel Therapeutics Announces New Data from Ongoing Phase 1 Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting
Treatment with CAN-3110 in arm A showed encouraging median overall survival rate at 11.8 months…
Taysha Gene Therapies Presents Preclinical Data on TSHA-102 for Rett Syndrome Demonstrating Cellular Regulation of MeCP2 Expression in Key Mouse Models at the American Society of Gene and Cell Therapy 26th Annual Meeting
New preclinical data after neonatal administration in wild-type mice showed no detectable impact on survival,…